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Abstract
Non-union is a fracture with no healing potential without a further surgical proce‐
dure. Diagnosis of non-union can be done in case of healing failure from 6 to 9 months
after the first fracture. We consider appropriate to keep the attention of the reader on
the relevance that  more frequent  traumatic  mechanisms have in  relationship with
evolution and eventual failure of healing processes. In literature, non-union mean rate
for tibial pilon fractures is around 5% independently from the synthesis technique
used;  as  main  causes  we  can  recognize  a  significant  fracture’s  comminution  ad
eventual bone loss, vascular damage, and local infection. Risk factors can be divided
into  two  big  groups:  factors  proper  of  the  patient  at  the  moment  of  injury  (age,
diseases, drugs, smoke, etc.) and characteristics of the trauma itself (comminution and
dislocation of fragments, involvement of soft tissues, topography, distance between
fragments). Tibial pilon fractures are mainly caused by high-energy trauma. This kind
of dynamic determines not only more serious damage to the bone, but often cause
damage of the surrounding tissues. Following important lesions of the periosteum and
of the vascular network and after a suboptimal synthesis caused by comminution and
dislocation of fragments is frequent with the evolution toward a bad bone healing
process. Bone healing was, in the last 50 years, argument of intense research activity.
The incidence of non-union is growing steadily, although principles and materials of
synthesys are well standardized. Recently it has been codified the “diamond concept,”
which clarified different  appliances mechanical  and biological,  these distinguished
between cells, scaffolds, and growth factors. Under the mechanical profile, it must be
restored  the  spectrum  of  stability  that  consider  the  set  of  bone  and  synthesis
implanted. The spectrum of stability interprets Wolf’s law providing indications on
the need to modulate the rigidity of the synthesis in reason of the level of instability
of the pseudoarthrosis itself. During the years several kinds of non-union classifica‐
tions have been proposed. The most widespread until now is the one proposed by
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Weber–Cech  in  1976,  which  distinguishes  vital  forms  (hypertrophic  and  oligotro‐
phic) from non-vital forms (atrophic). In 2007 a new score classification system has
been processed, which is the “Non-Union Scoring System (NUSS),” which divides
patients in four big groups by score awarded based on the real non-healing risk. The
NUSS represents an innovative approach to the problem because it understand the
multifactorial  reasons  of  failure,  explains  why  in  a  variable  percentage  of  cases
(depending from de district affected), the healing is not obtained, even with a correct
treatment  and  above  all  make  possible  the  drafting  of  a  therapeutic  choice  algo‐
rithm. Biotechnologies at our disposal are synthetic growth factors, the autologous
growth factors  and platelet-rich plasma,  mesenchymal stem cells,  and scaffolds or
bone substitute. The biologic chamber represent the ideal site for bone regeneration;
it is a bio-reactor in which are present all those elements at the base of the concept of
diamond. The chamber needs to be aseptic, vital, mechanically stable, and sealed but
selectively  permeable.  Thanks  to  the  use  of  megaprosthesis  not  only  in  oncologic
orthopaedics, but also it is now possible to avoid the amputation or long and often
inconclusive  treatment  of  lengthening  or  ankle  arthrodesis.  The  new  frontier  in
treatment of non-unions will be genetic therapy, that is, the possibility to transport to
the patient those genes that con drive to the formation of good bone callus and his
maturation toward strong bone.
Keywords: Tibial pilon, tibial plafond, non-union, biological chamber, biotechnolo‐
gies, NUSS, megaprosthesis, stem cells, growth factor, diamond concept
1. Definition
Non-union is a fracture with no healing potential without a further surgical procedure. Diagnosis
of non-union can be done in case of healing failure from 6 to 9 months after the first fracture.
Time is variable between fracture types, at the level of the tibial pilon diagnosis can be done
only 9 months after trauma. Between long bones, tibia is the most frequently involved by this
complication.
We consider appropriate to keep the attention of the reader on the relevance that more frequent
traumatic mechanism have in relationship with evolution and eventual failure of healing
processes.
As known, tibial plafond fractures are mainly caused by axial overload more than torsional
forces, that are, responsible more frequently of malleolus fractures.
The mechanism of axial overload presupposes a major transfer of energy which leads to a more
rapid deformation of the bone tissue until resistance limit is reached. The energy released at
the broken point to soft tissues surrounding causes characteristics soft tissues lesions, which
are present in those kinds of fractures and make the healing more complex: associated
fractures, dislocation of the astragalus; vascular and nervous lesions; muscle and skin lesions
with comparison of enlarged edema.
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2. Incidence
The tibial pilon non-union incidence in the literature ranges between 2 [1] and 18% for Ruedi
and Ovadia [2], and those results have been confirmed even by McFerran [3].
Studies of Havet in 2006 and Bacon and Wang in 2010 [4–6] report similar statistic data from
which result in similar non-union rate independently from the kind of ostheosynthesis used.
After those premises and therapeutic compromises sometimes adopted in treatment of the
tibial pilon fractures, it is easy to understand the data present in literature for which non-union
mean rate is around 5% independently from the technique used, recognizing as main causes
a significant fracture’s comminution ad eventual bone loss, vascular damage, and local
infection [4–7].
3. Risk factor
At this moment, we are able to classify risk factors, related to the establishment of non-union,
in two big groups: factors proper of the patient at the moment of injury and characteristics of
the trauma itself.
Between general risk factors, we can found advanced age (especially in female population
penalized by hormonal imbalances resulting from the menopause); non-compensated diabetes
(besides the well-known vascular and nervous disorders, it was observed a decrease in the
formation of collagen and cells involved in bone callus formation and maturation); osteopo‐
rosis; muscle atrophy; lifestyle (food, smoke, alcohol); drugs as NSAD, often prescribed against
pain after surgery (the reason of their bad influence on healing time is to be found in decreased
macrophagic activity and prostaglandin synthesis induced by COX 1 and 2 inhibition) [8].
Local risk factors, that are inherent to the trauma itself, include
• High-energy trauma (very frequent in tibial pilon fracture) in which occurs a greater
comminution and dislocation of fragments and a greater involvement of soft tissues and
vascular system, with heavy impact on blood support at the fracture’s site. Experimental
studies have demonstrated as the physiological healing process is guided, with a peak 2
weeks after the trauma, by blood supply from the cortical bone. As a consequence, a wide
lesion of soft tissues and large hematoma, narrowing blood support to the cortex itself,
reduce the inflow of nutrients and osteogenic cell to the fracture site, condition that
determine an increased risk of necrosis and delayed healing, with possible evolution toward
atrophic pseudoarthrosis [9].
• Topography: metaphyseal and diaphyseal fractures have different healing time and a
different incidence of non-union, due to the bone callus synthesis process that involve
mainly spongy bone, highly vascularized, and with a faster regenerative kinetics [10].
• Interfragmentary distance: an excessive distance between bone fragments, or the presence
of a third fragment, induces to the onset of non-union [11]. In this situation, a correct
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anatomic reduction of fragments with the intent to preserve vascularization is a positive
prognostic factor.
Tibial pilon fractures are mainly caused by high-energy trauma. This kind of dynamic
determines not only more serious damage to the bone, but often cause damage of the sur‐
rounding tissues.
Following important lesions of the periosteum and of the vascular network and after a
suboptimal synthesis caused by comminution and dislocation of fragments is frequent with
the evolution toward a bad bone healing process.
After the end of the 1980s, thanks to statistic analysis proposed by authors as McFerran [3] and
Dillin [12] and, more recently Piper et al. [13], it was possible to clarify the importance of risk
factors that affect the prognosis of tibial pilon fractures.
Distal tibia is characterized by a relatively poor vascularization and skin coverage. These
structures, when seriously damaged from the mechanism of injury, penalize the healing of
fractures.
There are several factors to whom was charged complicity in the development of such an
eventuality; among the most important, we find:
• A residual bone loss after the reduction of the fracture;
• The precariousness of the metaphyseal vascularization;
• A loss of skin coverage after injury;
• An inadequate mounting in case of external fixation synthesis;
• A wide deperiostization during synthesis with plate and screws.
Its, however, not negligible the eventuality that fractures of patients treated correctly, and with
low-risk rate, could evolve toward non-union.
It seems that the population of patients affected by non-union is somehow selected toward
those patients that present a higher risk of this complication. For this reason, it seems even
more important to analyze and classify these patients to define better surgical program and
even in some way to clarify the risk of treatment failure.
Is not a rare observation that some subject, unfortunately few in number, even if treated not
correctly shows “miraculous healing.” Instead, is greater the number of patients that, although
treated in a good way, under go several in effective surgical procedures.
4. Bone healing
Bone healing was, in the last 50 years, argument of intense research activity. The number of
non-union is constantly growing although principles and material of synthesis are standar‐
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dized. This observation finds an explanation in increase of life expectancy, in a population of
female and “young” senior addicted to activities at risk of injuries and in survival to car crash
deadly until few years ago. But does not clarify the feedback of those cases which, even after
good cares, does not undergo to healing.
It can be reasonably supposed that the improvement of cares offered to the injured patient has
in some way modified the population of patients with non-union.
In the past surgical errors, lack of knowledge of biomechanical principles that guide a good
synthesis and low-quality materials created cases of non-union that need only a more correct
treatment.
Recently is been codified the “diamond concept” that clarified different appliances mechanical
and biological, these distinguished between cells, scaffolds, and growth factors [14].
Under the mechanical profile, it must be restored the spectrum of stability that consider the
set of bone and synthesis implanted. The spectrum of stability interprets Wolf’s law providing
indications on the need to modulate the rigidity of the synthesis in reason of the level of
instability of the pseudoarthrosis itself [15].
5. Non-union classification
To be able to encode treatment’s guidelines, we must first proceed to a correct nosological
assessment of the problem. During the years, it has been proposed several kinds of non-union
classifications.
The most widespread until now is the one proposed by Weber–Cech in 1976, which distin‐
guishes vital forms, hypertrophic, and oligotrophic, or rather with possible biologic response,
from non-vital forms or rather non-reactive atrophic kind, frequently accompanied by
osteonecrosis, and even by bone loss [16].
This classification is based on a descriptive radiological analysis of the kind of non-union
evaluating only the bone, we think that a more complete classification, even from a prognostic
point of view, should take into account even the quality of soft tissues and the general
conditions of the patient (comorbidity, lifestyle, drugs, genetic diseases).
For this reason in 2007 have been identified through the study of international literature all
possible risk factors in the healing of fractures [8].
After has been processed a score classification system, the “Non-Union Scoring System
(NUSS)” [17] with double finality: not to detect a “radiographic case” but a “patient” and then
detect, in relationship with the real non-healing risk, those cases in which is necessary, not
only a correct surgical treatment, but even a right biotechnological approach. The NUSS
represents an innovative approach to the problem because it understand the multifactorial
reasons of failure, explains why in a variable percentage of cases (depending from de district
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affected) the healing is not obtained, even with a correct treatment and above all make possible
the drafting of a therapeutic choice algorithm [18, 19].
6. The NUSS
In the new NUSS classification of 2008 are considered all the variables and all risk factors,
giving to anyone a score based on clinical experience and scientific evidences and defining so
a treatment guideline depending from the final score [17].
The final score, obtained by the sum of the individual score, allows to compare different
patients with different non-union, making them objectively comparable according to a
principle of complexity.
Atrophic forms of non-union can have better prognosis and greater chance of healing than
oligotrophic reactive forms, in patients affected by impaired general health condition, as in
example a non-compensated diabetes.
7. The variables considered are as follows:
• The bone (quality, kind of fracture, number of previous surgical procedures, and their
invasiveness, non-union classification according to Weber–Cech, adequate first surgical
procedure in order to mechanical stability, bone gap, alignment);
• Soft tissues (tissues conditions, vascurarization and possible surgical procedures on soft
tissues and skin coverage);
• The patient (ASA score—American Society of Anesthesiologists—diabetes, laboratorys
exams, infective condition, drugs, and smoke).
First group, score from 0 to 25, made mainly as mechanical problem, the treatment indicated
is the fracture stabilization, optimizing or changing the synthesis system.
Second group, score from 26 to 50, made the problem as both mechanical and biologic, the
treatment needs correction of the synthesis and biologic stimulation of the fracture site,
obtained with the help of physical means (magnetic electro-pulsated fields, extracorporeal
shock wave) or with the application of biotechnologies in monotherapy [20–22].
Third group with score from 51 to 75. Is a complex problem characterized by high gravity of
both biological and mechanical conditions? It is almost always required the resection of the
non-union site, and then, is present a bone loss that have to be restored. Next to bone transport
techniques with external fixator and tibiotarsal joint arthrodesis at the docking point, there is
indication to autologous bone transplant and biotechnologies (cells, scaffolds, and growth
factors) applied in polytherapy according to the principles of the “Biological Chamber” [23–
25] [case 1].
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Fourth group with score from 76 to 100. Are non-union of such gravity to be assimilated to an
almost unsolvable problem and so can require a limb amputation or the implant of megapro‐
thesis [case 2].
There are no doubt that the third group non-union (51–75 points) are the more difficult to treat
and often are those recalcitrant forms that come to experts after too many surgical procedures
without outcome.
In this group, we think is appropriate the application of biotechnologies in order to avoid
unnecessary use of economic resources.
8. Biotechnology
Biotechnology at our disposition are synthetic growth factors (GFs) as human bone morpho‐
genetic recombinant proteins (rh-BMPs), autologous growth factors (AGFs) contained in
platelet-enriched plasma (PRP), mesenchymal stem cells (MSCs), and scaffolds or bone
substitutes.
• Growth factors (GFs)
Since the second half of 1990s, it has been demonstrated that some growth factors act as
powerful stimulators of the in vitro osteoblastic proliferation and of the in vivo bone healing,
such as to turn out really useful in aiding the healing process if correctly applied at the site
of the lesion [26]. Thanks to the evolution of the tissue engineering, it is been possible to
produce the single growth factors with the recombinant-DNA technique, particularly the
rh-BMPs. Although they have been identified at least 40 different rh-BMPs, a clear clinical
demonstration of the osteoinductive potential is available only for the rh-BMP-7, also known
as osteogenic protein-1 (OP-1), and for the rh-BMP-2 [27], belonging to the transforming
growth factors family (TGF-β), whose receptors are expressed on chondrocytes and
osteoblasts [28]. The osteoinduction phenomenon is characterized by the transformation of
the perivascular mesenchymal cells in bone progenitor cells that can regenerate bone tissue.
The recombinant human osteogenic protein-1 (rh-OP-1), also known as rh-BMP-7 (epto‐
dermina-α), conveyed by type-I collagen, has been the first to be approved in the world to
treat non-union of long bones and in the USA as “humanitarian device exemption” (HDE)
in the treatment of spinal non-union. It allows, also, the regeneration from vascularized bone
and of healthy bone surrounding toward the inside deficient area. Thanks to several
preclinical and clinical studies, the efficacy of the use of rh-BMP-7 has been demonstrated
reporting in some studies success percentage between 85 and 89%; at the same time, it has
been found a real decrease of complications linked to the use of autologous bone, considered
even at this time the “gold standard” [29–38].
• Autologous growth factors (AGFs) and platelet-rich plasma (PRP)
The PRP is the most advanced product of the “blood management.” It is a biologically active
concentrate of mediators extracted from patient’s plasma and is a source of non-specific
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autologuos growth factors [platelet-derived growth factor (PDGF), TGF-β1-β2, insulin-like
growth factor type 1-2 (IGF1-2) and vascular endothelial growth factor (VEGF)] able to
stimulate bone, cartilage, and soft tissues healing processes on the site of use. It is charac‐
terized by an elevate concentration of trombocytes able to degranulate releasing several
growth factors and cytokines that can induce osteogenesis and angiogenesis with a chemo‐
tactic and mitogenic mechanism [39]. It can be obtained from autologous or heterologous
blood. Depending from the procedure used to treat the withdrawal can be obtained final
platelet concentration from 4 to 8 times higher from the initial situation. In a randomized
study of 2007 on 60 long-bones non-union has been demonstrated a minor healing capabil‐
ities by the PRP (63.8%) both in comparison with BMP-7 than to the autograft [30].
The AGFs contained in the PRP, as clarified by preclinical and clinical data, are promoters
of the cellular division (mitogenesis) nonspecific for the bone cells, unable to promote the
differentiation of the mesenchymal cells and to induce the formation of new bone tissue.
They seem to be not useful when used alone or in association with scaffold in treatment of
tibial pilon non-union.
• Mesenchymal stromal cells (MSCs)
Studies based on cellular therapies are concentrated on a rare non-hematopoietic cells
population, the MSCs, which are present in patient’s bone marrow and can be increased in
colture in an undifferentiated state [40, 41]. In addition to their pluripotent properties, the
MSCs are considered osteogenic progenitor cells with demonstrated ability to repair bone
defects [42]. Their concentration at bone marrow level, however, can result not ever elevated
[43, 44]. The influence of this factor seems to be fundamental to the aim to obtain the healing,
and there are clinical evidences that a better prognosis is obtained with a progenitor cells
concentration >1500/cm3. Recently, new techniques have become available to obviate to this
problem, between these patient’s bone marrow aspirate permit the mesenchymal stem cells
concentration directly in the operatory room. Those new methods have demonstrated two
big advantages: a reduction in costs respect to the in vitro expansion of the MSCs and a
drastic decrease of the donor site morbidity compared to the traditional collection in open
surgery of the iliac crest [44, 45]. The clinical use of the MSCs, especially if associated with
the BMPs, it has proven effective determining the non-union healing [46].
• Scaffold
The osteoconduction mediated by the scaffold is determined by the chemical–physical
characteristics of the substratum act to favor the adhesion and the growth of the cells on the
surface. The mechanical characteristics of the bone graft, and their resistance to the com‐
pression and torsion, are influenced from their shape (massive, cortical splint, spongious
block, morcellized), from the withdrawal modality, processing, conservation, and from the
kind of synthesis meaning used.
The synthesis substitutes used are mineral structures similar to human bone kind. They
have only osteoconductive power. Between synthesis substitutes you can find calcium
phosphate as hydroxyapatite, coralline hydroxyapatite (absorbable), tricalcium phosphate
(TCP, absorbable), and biphasic calcium phosphate (BCP = HA + TCP). For small defects,
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the hydroxyapatite is good filler ad favorite, thanks to their osteoconductive properties, the
progressive revascularization and reossification of the treated area. All materials available
have some limit. Ceramic, particularly, presents three important disadvantages: the
difficulty to remain in place, the long time needed to absorption, and the complete substi‐
tution with neoformed bone and the impossibility to fill important bone gap.
The allogenic transplant from bone bank and heterologous animal origin (porcine, bovine,
or equine) have demonstrate osteoconductive power but not osteoinductive. They need,
then, to be revascularization and repopulated from the outside, needing a surrounding
enabling environment. Con be used as filler (morcellized/granules) or as mechanical support
(wedges, blocks, splints) [47, 48].
9. Biological chamber and polytherapy
The biological chamber is a concept that represents the ideal site in which to brought out the
bone regeneration processes. Is a natural bio-reactor within which are present all the elements
at the base of the diamond concept. It is even, physically, the site of non-union or of bone loss
specially prepared from the surgeon with the aim to create the best condition for the regener‐
ation. The chamber has to be aseptic, mechanically stable, and sealed in a selectively permeable
way [25].
To use the chamber is necessary to remove completely the pathologic non-union tissue,
removing all external bodies and meaning of synthesis. Is important to remove in a complete
way all the necrotic tissue up to a bleeding bone resection that means vitality. The non-union
tissue can be assimilated to a “meta-traumatic tumor” and as such, it must be removed entirely.
In case of non-union or septic bone loss is important to do cultural withdrawal with the aim
to identify the pathogen responsible of sepsis and perform targeted antibiotic therapy. Over
the removal of the infected bone tissue is important to do a debridement and an accurate toilette
of the soft tissues.
In septic cases is always preferable to do a two times treatment, then, once performed the
removal of the pathologic tissue need to be implanted a cement spacer usually two antibiotics
added (the choice of the active principle has to be done on the base of the antibiogram, when
available) able to sterilize the site and create a reactive pseudo synovial membrane (described
by Masquelet) extremely useful in the second reconstructive time [49].
In non-septic cases you can run a single surgical time reconstruction. Once created the
biological chamber is then possible to insert within it polytherapy, or rather the simultaneous
application of the three elements at the base of the diamond concept (growth factors, mesen‐
chymal stem cells, and scaffolds). The fourth element, that is mechanical stability, will be
provided by ostheosynthesis meaning (angular stability plates).
Case 1 (Figures 1–4)
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Figure 1. Clinical case 1—Man, 49 years, initial trauma following a motorcycle accident in which suffered exposed tibi‐
al pilon fracture, four ineffective treatments previously, comes to our attention (see X-rays and TC images) with a pic‐
ture of septic non-union with serious bone loss and varus deformity, NUSS: 56 points.
Figure 2. Intraoperative pictures that evidence: non-union site (a). Osteotomy with cruentation and removal of the
pathologic tissue saving the joint surface came to healing after all previous treatments (b). The creation of the “biologi‐
cal chamber” (c). The implantation of antibiotic cement added with gentamicin and clindamycin (d).
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Figure 3. Radiographic post-op images that evidence the stabilization with external fixation, the positioning of the ce‐
ment spacer and the deformity correction.
Figure 4. X-rays post-op images after the second reconstructive surgery performed by grafting biotechnologies in poly‐
therapy and stabilization with double angular stability plate (a). CT control after 9 months (b).
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10. Megaprosthesis
The development of megaprosthesis in serious segmental bon defects happened thanks to the
biomedical application of the metallurgic industry on the field of surgical oncology. The
development of new prosthesis for large resections offered important opportunities to
oncologic orthopaedic surgeons for the substitution of skeletal segment, as long bones of the
upper and lower limbs and near joints.
Our experience in treatment of non-union and serious bone loss led us, sometimes, to confront
with the reality of some failure, after futile attempts to reconstruct the bone, eve with the use
of advanced technologies as biotechnologies in monotherapy or polytherapy. In case of
patients with a NUSS score of 76–100, the severity of the lesions and the clinical conditions
usually makes sure that the surgical options of arthrodesis and amputation are implemented.
In front of these drastic situations, radiologic and clinic, and to patients that have no intention
to consider the amputation as a solution of their problem, we decided to apply the principles
of the oncologic surgery, trying to remedy at their extreme cases with a solution of massive
prosthetic [50, 51].
Actually in commerce you can find modular prosthetic system able to replace the entire femur
including hip and knee joints up to the distal third of the tibia.
This surgical instrument presents peculiar characteristics:
• Custom-made realized on radiologic images,
• Stabilized with a tibial stem and a talocalcaneal stem locked with a screw,
• It allows to be stretched according to the necessity on the way to restore the correct length
of the lower limbs,
• It offers the possibility to be resurfaced by silver in septic cases, exploiting the bacteriostatic
action of this element.
Thanks to these new implants are now possible to avoid the amputation or long and often
inconclusive treatments of lengthening and arthrodesis of the ankle with external fixators.
Those patients, being part of the fourth NUSS category, cannot have benefit nor from the
application of biotechnologies because the real possibilities of regeneration of the subject are
too compromised. Therefore in those patients, we think more opportune to do a substitution
treatment that can give back the function to the patient rapidly rather than follow again useful
reconstruction attempts. More studies will be carried out to value the efficacy and the longevity
of those new instruments.
Case 2 (Figures 5–7)
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Figure 5. Clinical case 2—man, 46 years, initial injury following an accident on work in which suffered of comminuted
tibial pilon fracture treated with synthesis with plate and complicated by septic condition. Comes to our attention with
bone defect of the tibial distal epiphysis and severe bone loss with bone exposition and deep sepsis after the removal
of the synthesis means and stabilization with external fixation. NUSS: 78 points. On the left X-rays and CT images, on
the right intraoperative picture after the resection of the distal tibia, evident the severe skin loss that has been treated
by covering flap.
Figure 6. X-rays post-op images that evidence the stabilization with external fixator and positioning of antibiotic ce‐
ment spacer with gentamicin and clindamycin (a), and after 3 months, resolved the septic condition, after the removal
of the external fixator (b).
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Figure 7. X-rays post-op images (a) after the implant of arthrodesing megaprosthesis of the distal leg (b) and clinical
pictures (c) of the operated limb and of the skin condition.
11. Conclusions and future perspectives
The objective difficulty of those specific cases, evidenced or classified correctly by an elevated
NUSS, cannot be representative in cases in which, in front of presumable mechanic necessities
and correct surgical treatment, presents real biological difficulties.
This biologic difficulty is presumable to be searched in genetic expression [52, 53] but is difficult
to assess in her real essential components and even more in the single clinical case.
The even more depth study of those which are the causes that can induce to non-union is today
more important than ever. The new frontier will be the gene therapy or rather the possibility
to transport inside the patient those genes acted to determine the succession of events that
conduce to the formation of a bone callus and his maturation to strong bone.
Several studies, on animals, evidence today show that the gene therapy is viable both with the
use of carrier virus [54, 55], both with the use of other non-viral carrier as for example particular
pulsed electric fields (DNA electroporation) [56]. These therapies are still futuristic realities
and provide an ulterior wide preclinic and clinic evaluation. A lot of road has been done until
today on the ground of knowledge and of clinic treatment of non-union, and we think that in
Advanced Techniques in Bone Regeneration120
the near future there will be understanding of how the non-union pathology could be by herself
a pathology on a vulnerable patient.
In these patients in which the regeneration possibilities are compromised, a valid solution is
offered from the biological chamber and from the new mega prosthetic implants that can avoid
the amputation and restoring the function to the patient.
Is today recognized the importance of a global and polyspecialists approach in the treatment
of non-union and of large bone loss of the tibial pilon? Recent studies costs–benefits on the
choice of the most appropriate treatment have demonstrate that the probabilities of a better
outcome offered by multidisciplinary approach with biotechnology have a fewer impact on
the sanitary economy compared to that expected for long-time care in case of repeated features
[57].
It is therefore our opinion that the use of secure and trusted traditional techniques must be
accompanied by the best is offered today by new technologies both on the respect of the quality
of patient’s life, both keeping in mind of the economic feasibility.
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